|1.||Kobayashi, Satsuki: 1 article (12/2010)|
|2.||Ueki, Kazue: 1 article (12/2010)|
|3.||Kuroiwa, Takashi: 1 article (12/2010)|
|4.||Matsumoto, Takayuki: 1 article (12/2010)|
|5.||Nojima, Yoshihisa: 1 article (12/2010)|
|6.||Hamatani, Hiroko: 1 article (12/2010)|
|7.||Yoshida, Hiroaki: 1 article (12/2010)|
|8.||Kobatake, Keiko: 1 article (12/2010)|
|9.||Kayakabe, Ken: 1 article (12/2010)|
|10.||Hiromura, Keiju: 1 article (12/2010)|
10/01/1993 - "In conclusion, this study indicates Perycit is effective for anti-hyperlipemia as well as for aiding improvement of sexual dysfunction. "
01/01/1985 - "It is concluded that Perycit has antilipemic effects in patients with idiopathic hyperlipidemia, and may be helpful in reducing the atherogenic risks in these patients. "
10/01/1993 - "Perycit (Pentaerythriol Tetranicotinate), a slow releasing drug, is one of the drugs used for treating hyperlipemia. "
10/01/1993 - "This study investigates the clinical effect, both objective and subjective of Perycit on anti-hyperlipemia as well as on impotence. "
04/01/2003 - "Antiproteinuric effect of niceritrol, a nicotinic acid derivative, in chronic renal disease with hyperlipidemia: a randomized trial."
11/01/1980 - "Niceritrol is thought to be effective in preventing the development and progression of atherosclerosis because it raises the level of anti-atherogenic HDL-Ch and lowers the level of atherogenic VLDL- + LDL-Ch."
04/01/1985 - "Because flushing, the most frequent side effect of niceritrol, can be easily controlled by a low dose of ASA, and because the combination of the 2 drugs has some beneficial effects on blood rheology, this combination is considered worthwhile for treatment and prevention of atherosclerosis."
02/01/1978 - "Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs."
01/01/1975 - "The effect of niceritrol (pentaerythritoltetranicotinate) on experimental atherosclerosis in cholesterol-fed rabbits at different levels of plasma cholesterol."
05/01/1976 - "A nicotinic acid ester and experimental atherosclerosis: no significant effect of treatment with niceritrol (pentaerythritoltetranicotinate) on cholesterol in aorta of rabbits previously fed with cholesterol-enriched diet."
|3.||Diabetic Neuropathies (Diabetic Neuropathy)
11/01/1994 - "Our results suggest that the C64 quantitative tuning fork is a convenient and objective tool for assessing the severity of diabetic neuropathy and that niceritrol is useful for the treatment of this disease."
11/01/1994 - "Use of the C64 quantitative tuning fork and the effect of niceritrol in diabetic neuropathy."
05/01/1992 - "Effect of niceritrol on streptozocin-induced diabetic neuropathy in rats."
07/01/1995 - "These observations suggest that ischemia/hypoxia plays an important role in the development of diabetic neuropathy, and that niceritrol has a therapeutic effect on this condition by improving endoneurial ischemia/hypoxia."
07/01/1995 - "The effect of treatment with niceritrol, a nicotinic acid derivative that acts as a vasodilator and reduces serum lipid concentrations, on 2,3-diphosphoglycerate concentration and diabetic neuropathy was also examined. "
12/01/2010 - "She was also treated with niceritrol, resulting in an improvement in her proteinuria and renal function. "
12/01/2010 - "After switching from pravastatin to niceritrol, a marked reduction in the proteinuria and an improvement in renal function were observed. "
04/01/2003 - "We administered niceritrol, a nicotinic acid derivative, to patients with chronic renal disease and a high serum Lp(a) level, and studied its effects on lipid metabolism, proteinuria, and renal function. "
11/01/1994 - "Niceritrol significantly improved measures of neurologic function (vibratory sensation scores, MNCV of the upper extremities, and sensory nerve conduction velocity of the lower extremities; P < 0.05 to 0.001), and subjective symptoms (numbness, cold, desensitization, and spontaneous pain in the lower extremities; P < 0.01 to 0.001). "
|2.||Thyrotropin (Thyroid-Stimulating Hormone)
|4.||Niacin (Nicotinic Acid)
|1.||Renal Dialysis (Hemodialysis)
|2.||Fat-Restricted Diet (Diet, Fat Restricted)
|3.||Blood Component Removal (Apheresis)